| Describe the diagnosis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder. |
|
|
|
|
|
|
| Describe the pathogenesis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder. |
|
|
|
|
|
|
| Discuss evidence-based treatment approaches for muscle-invasive and metastatic urothelial carcinoma of the bladder. |
|
|
|
|
|
|